Advertisement

Topics

OctreoPharm Sciences GmbH Company Profile

00:58 EDT 22nd April 2018 | BioPortfolio

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control of tumors. Current shareholder of OctreoPharm Sciences GmbH are Eckert & Ziegler AG, VC Funds Technology managed by IBB Berlin GmbH, KfW Mittelstandsbank, Eckert Life Science Accelerator GmbH, OctreoPharm (Holding) GmbH and the Chinese investor Shaanxi Xinyida Investment Co. Ltd.


News Articles [675 Associated News Articles listed on BioPortfolio]

BIOCRATES Life Sciences AG Acquires Metanomics Health GmbH

BIOCRATES Life Sciences AG announced the acquisition of Metanomics Health GmbH. Metanomics Health is a metabolomics biomarker development and healthcare services specialist based in Berlin, Germany. A...

Arbutus, Roivant further existing RNA deal through formation of Genevant JV

Continuing a relationship that began last year, Arbutus Biopharma Corp. and Roivant Sciences GMBH entered a new agreement in which they aim to further the efforts of their hepatitis B virus (HBV) part...

Nabriva grants Sinovant lefamulin rights in greater China

Nabriva Therapeutics PLC licensed Roivant Sciences GMBH's Sinovant Sciences Ltd. subsidiary exclusive rights to develop and commercialize the antibacterial candidate lefamulin in China, Hong Kong, Mac...

ArQule grants Roivant/Sinovant exclusive derazantinib rights in China

ArQule Inc. granted Roivant Sciences GMBH and its Sinovant Sciences Ltd. division exclusive rights to develop, manufacture, and sell in China, Hong Kong, Macau, and Taiwan the investigational cancer c...

Super Saver Rate Ending for San Diego Life Sciences 2022 on December 11

When Xconomy gathered a handful of life sciences visionaries in 2010 to predict what the local life sciences landscape would look like in 2030, biotech CEO John Mendlein talked about the intertwining ...

Original-Research: Medigene AG (von EQUITS GmbH): Kaufen

Original-Research: Medigene AG - von EQUITS GmbH Einstufung von EQUITS GmbH zu Medigene AG Unternehmen: Medigene AG ISIN: DE000A1X3W00 Anlass der Studie: Übernahme-Angebot Empfehlung: Kaufen Kursz...

Roivant gets rights to HanAll's autoimmune disease candidate

HanAll BioPharma Co. Ltd. granted Roivant Sciences GMBH exclusive rights to develop, manufacture, and sell its Phase I anti-FcRn monoclonal antibody HL161 for pathogenic IgG-mediated autoimmune diseas...

PH-FIX Indikatorstäbchen pH 4,5-10 100 St MACHEREY-NAGEL GMBH & CO. KG

EUR 10,24Angebotsende: Samstag Apr-7-2018 11:22:08 CESTSofort-Kaufen für nur: EUR 10,24Sofort-Kaufen | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : PH-FIX Indikatorstäbchen pH 4,...

PubMed Articles [676 Associated PubMed Articles listed on BioPortfolio]

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Acknowledgement to Reviewers of Veterinary Sciences in 2017.

Peer review is an essential part in the publication process, ensuring that Veterinary Sciences maintains high quality standards for its published papers[...].

Journal of Gerontology: Biological Sciences. A Long Tradition in Advancing Aging Biology and Translational Gerontology.

Sex and aging.

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Clinical Trials [216 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

M-learning to Improve Professional Competencies in Health Sciences

The aim of this study is to investigate whether a mobile application is useful for improving knowledge about professional competencies in students enrolled in Health Sciences degrees.

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Cognitive Rehabilitation With C8 Sciences

C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...

Companies [1561 Associated Companies listed on BioPortfolio]

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

Medea AV GmbH

medea AV GmbH is the manufacturer of the medeaLAB Imaging Systems. 20 years of experience in image processing contributed to our image analysis systems for research and industry. We develop specialize...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

More Information about "OctreoPharm Sciences GmbH" on BioPortfolio

We have published hundreds of OctreoPharm Sciences GmbH news stories on BioPortfolio along with dozens of OctreoPharm Sciences GmbH Clinical Trials and PubMed Articles about OctreoPharm Sciences GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of OctreoPharm Sciences GmbH Companies in our database. You can also find out about relevant OctreoPharm Sciences GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record